Northern Biologics Inc.

About:

Northern Biologics use state-of-the-art antibody discovery to tackle novel and challenging targets in oncology and fibrosis.

Website: http://northernbiologics.com/

Top Investors: Criteria Venture Tech, Sixty Degree Capital

Description:

Northern Biologics use state-of-the-art antibody discovery to tackle novel and challenging targets in oncology and fibrosis. Its therapeutic antibody candidates are derived from a state-of-the-art phage display platform developed and refined by world-leading researchers at the University of Toronto, and we focus on developing novel functional modulators of key signaling pathways in cancer and fibrosis. Northern Biologics was founded in 2014 and headquartered in Toronto, Ontario, Canada.

Total Funding Amount:

$7.29M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Toronto, Ontario, Canada

Founded Date:

2014-01-01

Contact Email:

info(AT)northernbiologics.com

Founders:

Benjamin Neel, Rob Rottapel

Number of Employees:

11-50

Last Funding Date:

2019-06-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai